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Summary 
We have recently described a novel glycoprotein, Kp43, expressed on the surface of human natural 
killer (NK) cells that appears to regulate their functional activity. In this report, signaling mechanisms 
through the Kp43 surface antigen have been studied. Incubation of interleukin 2 (IL-2)-treated 
NK cells with anti-Kp43 monoclonal antibody F(ab')2 fragments resulted in the time- and dose- 
dependent stimulation of NK cell phospholipase D.  Phospholipase D  activation through the 
Kp43 surface antigen was found to take place in the absence of polyphosphoinositide turnover 
and appeared not to depend on the presence of Ca  2  + in the extracellular medium. On the other 
hand, signaling mechanisms through the CD16 receptor (FcR-III) on NK cells were comparatively 
studied.  Stimulation of IL-2-treated  NK cells with anti-CD16  monoclonal antibody F(ab')2 
fragment also resulted in time- and dose-dependent activation of phospholipase D.  However, 
CD16-triggered phospholipase D activation took place concomitant to phospholipase C-mediated 
polyphosphoinositide  breakdown and showed a strong dependence on extracellular Ca  2+ . These 
results provide, to our knowledge, the first evidence for the presence of activatable phospholipase 
D  in NK cells, as well as the first indication that distinct receptor-modulated pathways exist 
for activation of phospholipase D within the same cell type. On the other hand, phosphatidic 
acid, the physiologic product of phospholipase D action on phospholipids, was found to mimic 
the effect of anti-Kp43 monoclonal antibody regarding tumor necrosis factor o~ (TNF-ol) biosynthesis 
and secretion by NK cells. Addition of phosphatidic acid vesicles to Ib2-treated NK cell cultures 
stimulated a TNF-ol production that was abolished when the cells were previously treated with 
actinomycin D. Other phospholipids, including lysophosphatidic acid, were ineffective. However, 
phosphatidic acid-induced TNF-c~ production was strongly inhibited by the presence of propranolol, 
an inhibitor of phosphatidic acid phosphohydrolase. Moreover,  in cells responding to phorbol 
myristate acetate,  a compound that triggers activation of phospholipase D,  TNF-c~ synthesis 
was also inhibited by propranolol. Thus, these data suggest a second messenger role for phosphatidic 
acid-derived diradylglycerol in the induction of TNF-c~ gene expression. 
H 
'uman NK cells are phenotypically defined as CD3- 
￿9  large granular lymphocytes expressing the CD16 (FcK- 
III) and the CD56 surface antigens (1). NK cells are able to 
mediate MHC-unrestricted cytotoxicity, secrete cytokines, and 
proliferate in response to IL-2. This lymphoid cell subset has 
been proposed to play a key effector role in nonadaptive im- 
munity and is believed to be involved in host defense against 
microbial infection and tumor cell growth, as well as in the 
regulation of hematopoiesis (1). 
Although NK cells comprise only 10-15% of total human 
PBL, the possibility of expanding in vitro NK cell popula- 
tions (2) and clones (3) has enabled a considerable  advance 
in the knowledge of NK cell biology, and of the molecular 
mechanisms that underlie NK cell activation. It has been 
reported that NK cell stimulation through the CD16 antigen 
triggers phospholipase C hydrolysis of polyphosphoinositides, 
intracellular Ca  2+ mobilization, and Ca  ~+ influx across the 
plasma membrane (4). The CD16 antigen is coupled to the 
~" chain of the CD3 complex, which is believed to play a key 
role in signal transduction (5). Phospholipase C  activation 
via the CD16 receptor has been reported to be mediated 
through a cholera toxin-sensitive GTP-binding protein (6). 
J. Exp.  Med. ￿9  The Rockefeller  University Press ￿9 0022-1007/92/07/0009/09  $2.00 
Volume  176  July 1992  9-17 Nonetheless, little is known about signaling mechanisms in- 
volving  activation  of other intracellular  phospholipases  in 
human  NK cells. 
We have recently described a novel glycoprotein, termed 
Kp43, that is expressed on the surface of human NK cells, 
and appears to be involved in the regulation of IL-2-treated 
NK cell function (7, 8). Anti-Kp43 rnAb induces cytolytic 
activity against  normal T  cell blasts (8),  and enhances the 
synthesis of TNF-c~ (J. Aramburu, A. Kodrlguez-M~rquez, 
M.  A.  Balboa, and M.  L6pez-Botet, manuscript  in prepa- 
ration). 
The present study was undertaken to address the issue of 
signal transduction  through  the Kp43 molecule in human 
NK cells.  In  addition,  signaling  mechanisms  through  the 
CD16 surface antigen were comparatively investigated. Our 
results demonstrate receptor-regulated phospholipase D  ac- 
tivity through two different NK cell-associated surface mol- 
ecules,  namely  Kp43  and  CD16.  This  is  the  first  report 
documenting phospholipase D activation in human NK calls. 
In addition,  this study provides evidence that  at least two 
different receptor-modulated pathways exist for activation of 
phospholipase D  in a single cell type. Moreover, our results 
suggest a role for phosphatidic acid-derived diradylglycerol, 
a product of phospholipase D  action on phospholipids,  in 
the biosynthesis of TNF-c~ by NK cells. 
Materials  and Methods 
Materials.  Cell culture medium, FCS, penicillin, streptomycin, 
and L-glutamine were purchased from Flow Laboratories (Irvine, 
Scotland). [3H]Palmitic acid (sp act, 54 Ci/mmol),  my0[~H]inositol 
(sp act,  20.8 Ci/mmol),  and H3132p]o4 (sp act,  10 mCi/mmol) 
were from Amersham International  (Amersham,  England).  Pro- 
tein A-Sepharose was from Pharmacia (Uppsala, Sweden). PMA, 
fura-2/AM,  pepsin, phospholipids, actinomycin D, and propran- 
olol were from Sigma Chemical Co. (St. Louis, MO). G-60 thin- 
layer chromatography  plates and the organic solvents (analytical 
grade) were from Scharlau (Barcelona, Spain). Phosphatidylethanol 
(PEt) 1 standard was prepared from egg lecithin as described (9). 
Ib2 was generously provided by Hoffmann-La Roche (Basel, Swit- 
zerland). 
Monoclonal Antibodies.  The anti-Kp43 mAb, HP3B1 (IgG2a), 
obtained against activated NK cells, has been previously described 
(7, 8). The anti-CD16 mAb, B73.1 (IgG1), was a kind gift from 
Dr. B. Perussia (The Wistar Institute, Philadelphia, PA). Anti-CD56 
mAb, Leu19, was purchased from Becton Dickinson & Co. (Moun- 
tain View, CA). Anti-CD3 mAb, SPV:F3b (IgG2a) (10), was kindly 
provided by Dr. J. de Vries (Unicet Laboratories, Dardilly, France). 
Anti-CD2 mAb, TS2/18 (IgG2a) (11), was a kind gift from Dr. 
F. S~nchez-Madrid (Hospital de la Princesa, Madrid, Spain). Anti- 
O2-microglobulin mAb, HP1H8 (IgG3), was obtained in our lab- 
oratory.  F(ab')2 anti-mouse IgG antiserum  was purchased from 
Sigma Chemical Co. 
F(atr  Preparation.  F(ab')2 fragments  from  affinity-purified 
mAb were prepared by pepsin digestion and separated from un- 
digested  IgG  and  Fc fragments  by passage through  a protein 
A-Sepharose column as described (12). 
Cells.  All experiments were performed with NK cells obtained 
1 Abbreviations  used in this paper: DG, 1,2-diradylglycerol;  PA, phosphatidic 
acid; PEt, phosphatidylethanol. 
from short-term cultures of PBMC with the irradiated Daudi tumor 
B cell line as previously described (2, 7, 8). NK cells were purified 
from 6-7-d-old cultures by negative selection using anti-CD3 mAb 
and rabbit complement (Behring, Marburg, Germany). These popu- 
lations were later expanded with 50-100 U/ml IL-2 (7, 8), and will 
be referred throughout the paper to as IL-2-treated NK cells. Be- 
fore performing the assays, the surface phenotype of cultured NK 
cells was analyzed by indirect immunofluorescence labeling with 
CD2-, CD7-, CD16-, CD56-, and Kp43-specific  mAbs. The results 
were  comparable  to  those  previously  described  (<5%  CD3+; 
>95% CD2 +, CD7 +, CD16 +, CD56 +, Kp43 §  (7, 8). 
Preparation of Laboled Cells, Incubation Conditions, and Lipid Ex- 
traction.  Labeling of ceils with [3H]palmitic acid or [3H]inositol 
was accomplished by adding  these radioactive precursors at  10 
/~Ci/ml overnight to the culture medium. [3H]Palmitic acid in tol- 
uene was taken to dryness under a gentle stream of nitrogen,  and 
the residue was dissolved in 0.1 M NaOH (13) and diluted with 
fresh medium before addition to cell cultures. For 32p labeling, cells 
were incubated overnight with 20/~Ci/ml H3132p]o4. Appropri- 
ately labded cells were resuspended in HG buffer (150 mM NaC1, 
1.2 mM  MgC12, 1.3  mM  CaC12, 5.5  mM n-glucose,  10 mM 
Hepes, pH 7.5) to a concentration  of 107 cells/mE The reactions 
were initiated by adding either vehicle  or the corresponding stimulus, 
in the presence or absence of 0.5% ethanol Reactions were stopped 
by adding an equal volume of chloroform/methanol/hydrochloric 
acid (100:200:1) and lipids were extracted as described (14). 
For  preparation  of Ca2+-depleted cells, they were  incubated 
with I mM EGTA and 40/zM fura-2/AM in Ca  2+-free HG buffer, 
for 60 min at 37~  (15, 16), washed twice, and stimulated as ap- 
propriate,  either in presence or absence of 1 mM EGTA. 
Analysis of Lipids by Thin-Layer Chromatography.  After extrac- 
tion, the lipids in the lower organic phase were spotted onto Sillcagel 
G-60 plates. For PEt separation, plates were developed twice using 
the upper phase of a system consisting  of ethyl  acetate/2,2,4- 
trimethylpentane/acetic  acid/water  (110:50:20:100). This  system 
allows a good separation between phosphatidic acid (PA), PEt, and 
major phospholipids (17). For DG separation, plates were devel- 
oped twice with n-hexane/diethyl ether/acetic  acid (70:30:1) as a 
solvent system (18). 
Meafurement of  lnositol Phosphates Production.  Total  inositol phos- 
phates production was quantitated by anion-exchange chromatog- 
raphy as described (18, 19). 
TNF-ot  Production Assay.  NK  cells were  seeded in  round- 
bottomed 96-well plates (1.5  x  106 cells/m1, 200/~l/well final 
volume) in culture medium with 50 U/ml of rib2 and the different 
stimuli were added at the beginning of the assay. Lipids were added 
to the cells in the form of vesicles obtained by sonication in culture 
medium. After the appropriate incubation times, plates were cen- 
trifuged (200 g, 3 rain), and cell-free superuatants were collected. 
TNF-o~ concentration in the supernatants was measured by ELISA 
(Biokine TNF Test; T Call Sciences  Inc., Cambridge, MA). When 
the effect of a KNA synthesis inhibitor, actinomycin D, was tested, 
cells were preincubated for 30 rain with this compound (5/~g/ml) 
before addition  of the different stimuli. 
Results 
PEt Production  by IL2-treated NK Cells.  Unequivocal evi- 
dence for the involvement of phospholipase D  in stimulus- 
response coupling is the accumulation of phosphatidylalcohols 
when primary alcohols, such as ethanol,  are present during 
cell stimulation  (20).  These phospholipids  are not normal 
constituents of the cell membrane, and phospholipase D-cata- 
10  Phospholipase  D Activation in Human Natural Killer Cells Figure t.  PEt production  by Ib2-treated NK cells. 32p-labeled  NK cells 
were stimulated  with PMA (100 ng/ml) for 30 min in the presence (lane 
D) or absence  (lane  B) of  0.5% ethanol.  After  extraction,  lipids  were  sepa- 
rated by thin-layer  chromatography  as described  in Materials  and Methods, 
and the plate  was autoradiographed.  Lanes  A and C denote  control  incu- 
bations without PMA in the absence  or presence of ethanol, respectively. 
lyzed transphosphatidylation is the only known mechanism 
by which cells can form phosphatidylalcohols. Therefore, the 
formation of PEt is a sensitive  and specific assay for phos- 
pholipase D  activation. PEt formation was investigated in 
3zp-labeled IL-2-treated  NK cells stimulated by PMA (Fig. 
1).  PMA has been previously shown to optimally activate 
phospholipase D in human leukocytes (14, 21-23).  Thin-layer 
chromatography analyses of lipid extracts derived from PMA- 
stimulated NK cells exposed to ethanol revealed the presence 
of a unique spot (Fig. 1, lane D) that was not found in stimu- 
lated cells in the absence of ethanol (Fig.  1, lane B) nor in 
unstimulated cells either in the absence or presence  of eth- 
anol (Fig.  1, lanes A  and C). The spot was identified as PEt 
by comparison with a PEt standard (9).  Thus, these results 
provide the first evidence for the presence of a phospholipase 
D  activity in IL-2-activated NK cells that is regulated upon 
cell  stimulation. 
Interaction of mAb HP3B1  with the Kp43 Surface Antigen 
Enhances Phospholipase D  Activity  in  IL,2-treated NK  Cells. 
Experiments were conducted to determine the possible  in- 
volvement of phospholipase D  activity in NK cell stimula- 
tion through the Kp43 antigen.  [3H]Palmitic  acid-labeled 
cells were exposed to HP3B1 mAb F(ab')z fragments in the 
presence  of 0.5%  ethanol, and PEt production at different 
times was examined (Fig. 2 A). In these experiments PMA 
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Figure 2.  Formation  of PEt in IL-2-treated  NK cells stimulated  via the 
Kp43 antigen. [3H]Palmitic  acid-labeled  NK cells  were  incubated  in buffer 
containing  0.5% ethanol  and challenged  by 100 ng/ml PMA (A) or by 
3 #g/106 cells of HP3B1 anti-Kp43 mAb F(ab')2 fragments (0)  for 
different  times  (A), or by several  mAb concentrations  for 30 min (B). After 
extraction, lipids were separated  by thin-layer  chromatography,  and the 
radioactivity  was quantified  by liquid  scintillation  counting.  Data  correspond 
to the mean + SEM of four different  experiments, and are expressed  as 
percent production  with respect to unstimulated  controls  taken  at different 
times. The 100% value was 1,140 +  250 cpm. 
PMA and HP3B1 mAb F(ab')z fragments induced a time- 
dependent accumulation of PEt in IL-2-treated NK cells. The 
kinetics of PEt production by both stimuli was similar, the 
cell response to PMA being always higher than that to HP3B1 
(Fig. 2). The concentration-response relationship for HP3B1 
mAb F(ab')z fragment-induced PEt accumulation was inves- 
tigated, and the results are shown in Fig. 2 B. Increase  of 
[3H]PEt  accumulation was  observed  in  a  dose-dependent 
manner, the maximal response being reached at an antibody 
concentration of 1/~g/106 cells. 
PA and DG Production by IL-2-treated NK Cells Stimulated 
through the  Kp43  Surface Antigen.  Since  the  physiologic 
product of phospholipase D action on cellular phospholipids 
is PA, not PEt, the effect of HP3B1 mAb F(ab')z fragment 
on PA levels was investigated. PMA was used as a positive 
control (23).  [3H]Palmitic  acid-labeled PA levels increased 
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Figure 3.  Accumulation of PA and DG in stimulated NK cells. NK 
cells, prelabded with [3H]palmitic acid, were stimulated with 100 ng/ml 
PMA (A) or HP3B1 anti-Kp43 mAb F(ab')z fragments (3/~g/10~ ceils) 
(B), for the indicated times. After extraction, lipids were separated by thin- 
layer chromatography, and the radiography in PA (A, @) and DAG (A, 
O) was quantified by liquid scintillation counting. Values are shown as 
mean +  SEM of three different determinations in samples from different 
donors. The results are expressed as percent production with respect to 
unstimulated  controls. 100% values were 5,180 _+ 520 and 15,300 _+ 1,860 
for PA and DG, respectively. 
gradually, plateauing at 15 min and remaining unchanged 
thereafter (Fig. 3). Stimulated PA production by both PMA 
and HP3B1  showed similar kinetics, although,  as for PEt 
production, the cellular response to PMA was always higher 
than that to HP3B1. 
Experiments were also  conducted to  study  1,2-diradyl- 
glycerol (DG) production by stimulated NK cells. As shown 
in  Fig.  3,  both  PMA  and  HP3B1  induced  appreciable 
[3H]palmitoyl-labeled DG accumulation. 
Enhancement of Phospholipase D Activity in IL-2-treated NK 
Cells by Anti-CD16 mAh  To rule out the possibility that 
HP3Bl-induced PEt accumulation could be unspecific and 
not receptor mediated, we examined the effect of other mAbs 
on NK cell phospholipase D. The results are summarized in 
Table 1. It can be observed that neither HP1H8 mAb F(ab')2 
fragment (anti-~2-microglobulin) nor SPV-T3b mAb (anti- 
CD3) induced PEt accumulation. Therefore, these results in- 
dicate that  HP3Bl-induced  PEt  formation was  actually a 
receptor-triggered event. Remarkably, when we tested the 
effect of B73.1  mAb F(ab')2 fragment (anti-CD16),  an ap- 
preciable PEt production of similar magnitude to that in- 
duced by anti-Kp43 mAb was observed (Table 1). These data 
Stimulus  PEt production 
c~m 
None (control)  640  +  50 (100) 
PMA  2,340  _+ 240 (263) 
HP3B1  1,430  _+  170 (220) 
B73.1  1,320  _+  170 (210) 
HP1H8  620  +_ 40 (100) 
SPVT3b  700  _+  100 (109) 
IL-2-treated  NK cells, prelabeled with [3H]palmitic acid, were incubat- 
ed with stimuli listed above for 30 min, in the presence of 0.5% ethanol. 
PEt production was determined as described in Materials and Methods. 
All antibody preparations  were used as F(ab')z fragments  at 3/~g/106 
cells.  PMA  was  used  at  100  ng/ml.  Results  correspond  to  the 
mean  _+ SEM from a representative experiment of three performed. Num- 
bers in parentheses represent percent values referred to control. 
prove that occupancy of the CD16 receptor also stimulates 
NK cell phospholipase D. Thus, we characterized the anti- 
CD16 mAb-induced PEt production in IL-2-treated NK cells. 
As shown in Fig. 4, both the kinetics of PEt accumulation 
and the threshold concentration giving maximal PEt produc- 
tion in response to anti-CD16  mAb were similar to those 
previously observed for HP3Bl-stimulated cells (compare Figs. 
2  and  4).  Crosslinking  of CD16  receptors  with  F(ab')2 
mouse IgG antiserum did not appreciably modify PEt produc- 
tion (results not shown). 
Role of Ca  2+ in Receptor Stimulation of Phospholipase D  in 
IL,2-treated NK Cells.  Ca  2+ has been proposed to be a key 
regulator ofphospholipase D activity in human HL60 gran- 
ulocytes (21, 24), human U937 promonocytes (14), and human 
erythroleukemia cells and platelets (25, 26).  Therefore, we 
examined the involvement of Ca  ~+ in IL-2-treated NK cell 
phospholipase D  activation. The effect of both HP3B1 and 
B73.1 mAb F(ab')2 fragments on phospholipase C-mediated 
inositol phosphates production is shown in Fig. 5. As previ- 
ously reported by Cassatella  et al. (4),  B73.1-induced poly- 
phosphoinositide breakdown was noticeably augmented when 
a crosslinker was added to the incubation mixture (Fig.  5). 
These  data  agree with  the fact  that  occupancy of CD16 
receptors on IL-2-treated NK cells triggers Ca  2+  mobiliza- 
tion from internal stores (4,  8).  By contrast, HP3B1 mAb 
F(ab')2 fragments did not induce phospholipase C-mediated 
polyphosphoinositide breakdown. When a crosslinker was 
added, again no inositol phosphates production could be ob- 
served (Fig.  5).  It is noteworthy that NK cell stimulation 
through the Kp43 receptor is not associated  with changes 
in the intracellular Ca  2+  concentration (8). 
To analyze the possible involvement of extracellular Ca  2+ 
in the activation of NK cell phospholipase D, experiments 
were carried out in the presence or absence (EGTA-containing 
medium) of Ca  2  + in the incubation medium. As shown in 
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Figure 4.  PEt production  by NK cells stimulated via the CD16 receptor. 
[3H]Palmitic acid-labeled cells were stimulated by ]}73.1 anti-CD16  mAb 
F(ab')2 fragments (3/zg/106 cells) for different times (,4) or by several  mAb 
concentrations for 30 min (B), in the presence of 0.5% ethanol.  Data are 
shown as mean •  SEM of three different experiments,  and are expressed 
as percent production with respect to unstimulated  controls.  The 100% 
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Figure 5.  Phospholipase C-mediated hydrolysis of inositol phospholipids 
in NK cells stimulated either by anti-Kp43 or anti-CD16 mAbs. NK cells, 
prelabeled with myo[3H]inositol, were treated with FIP3]}I anti-Kp43 (@) 
or ]}73.1 (A) mAb F(ab')2 fragments  (3/~g/106  cells) for the indicated 
times. Total inositol phosphates production was determined  as described 
in Materials and Methods.  The arrow indicates addition of a F(ab')2 goat 
anti-mouse Ig antiserum (G anti-mlg) (50/~g/ml) as a crosslinker. Results 
are given as mean •  SEM from a representative experiment of two similar 
ones, and are expressed as percent  production with respect to unstimu- 
lated controls taken at different times. The 100% value was 860 •  100 cpm. 
to sustain receptor-mediated  activation of phospholipase D 
in NK cells. 
Stimulation of TNF-ot Biosynthesis in IL,2-treated NK Cells 
by PA-derived DG.  From the results shown in Fig. 3, it is 
apparent that stimulated PA accumulation in NK cells pre- 
cedes that of DG.  This  suggests  that PA may be a source 
of DG generated upon cell activation, as has been described 
in other cellular systems (27-31). A common feature of IL-2- 
treated  NK calls exposed either to PMA,  HP3B1 mAb,  or 
B73.1 mAb is the induction of TNF-o~ biosynthesis (32) (J. 
Aramburu, A. Kodrfguez-M~rquez, M. A. Balboa, and M. 
L6pez-Botet,  manuscript in preparation). As all of these stimuli 
Fig. 6, chelation of extracellular  Ca  u  + with EGTA led to a 
strong inhibition of B73.1-induced PEt accumulation. How- 
ever, PEt production in response to HP3B1 was unaffected 
(Fig.  6).  These  data  indicate,  therefore,  that  extracellular 
Ca  2§  is required for phospholipase D  activation  through the 
CD16 receptor but not through  the Kp43  antigen.  These 
findings are consistent  with previous  work demonstrating 
extraceUular Ca  2  + influx associated with CD16 receptor  oc- 
cupancy (4) but  not with  anti-Kp43  stimulation  (8). 
Receptor activation of PEt synthesis was also investigated 
in IL-2-treated NK cells pretreated  with 40/zM fura-2/AM 
in the presence of 1 mM EGTA,  a procedure that depletes 
the intracellular  Ca  2  + stores  and buffers  and clamps the in- 
tracellular Ca  2 + concentration at very low levels ('~10-s M) 
(15, 16). Under these conditions, PEt production by HP3B1- 
stimulated  Ib2-treated NK cells was completely  abolished 
(data not shown). Thus, the results suggest that a threshold 
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Figure 6.  Effect of Ca  2+ on receptor-stimulated  PEt production in NK 
cells. [3H]Palmitic acid-labeled NK cells were placed in buffer containing 
0.5% ethanol and stimulated  by HP3B1  (3 #g/106  cells) or by ]}73.1 (3 
/~g/106 cells) for 30 min, in the presence (open bars) or absence (hatched 
bars) of 1.3 mM CaC12 in the extracellular medium. PEt production was 
determined  as described in Materials and Methods.  Results  are given as 
mean  •  SEM of three  different  experiments. 
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NK cells were treated for 3 h with the stimuli listed above in a IL-2-con- 
taining medium (50 U/ml), either in the presence or absence of 5 #g/ml 
actinomycin D  (Act D).  The mAbs were used as F(ab')2 fragments at 
a concentration of 5/~g/ml. PMA was used at 20 ng/ml, and PA at 500 
#g/ml, in the form of sonicated vesicles. At the end of the 3-h period, 
cell-free  supernants were collected and assayed for TNF-o~  content as 
described in Materials and Methods. Values correspond to the mean _+ SEM 
of four determinations in samples  from different donors. 
activate phospholipase D, we examined the effect of adding 
PA directly to IL2-treated NK cell cultures on TNF-ol produc- 
tion. As well as HP3B1, B73.1,  and PMA, PA by itself was 
able to induce appreciable TNF-ol production (Table 2).  In 
as much as cell viability remained constant along the experi- 
ments, as measured by StCr release from SlCr-labeled  cells 
(data not shown), increase in supernatant levels of TNF-ot 
was not due to PA-induced cell damage. Cell-associated TNF-o~ 
levels before incubation with the different stimuli were 75 
+  25 pg/ml, as measured in NK cell homogenates obtained 
by freezing/thawing. To assess that PA-stimulated TNF-ol 
production was actually the consequence of a biosynthetic 
process,  experiments were performed in the presence of ac- 
tinomycin D, an inhibitor of mRNA transcription. As for 
Figure 7. 
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Effect of PA on TNF-o~ production by NK cells. Different 
concentrations of PA, in vesicle form, were added directly to cell cultures. 
After 3 h, the concentration of TNF-o~ in the supernatants was measured 
as described in Materials and Methods. Results are shown as mean _+ SEM 
of four different experiments. 
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Figure 8.  Effect of propranolol on PMA- and PA-induced TNF-~ produc- 
tion by NK cells. Cells were treated with PMA (20 ng/ml) (A), 500 ~g/ml 
PA (0), or neither (O) in the presence of the indicated amounts of pro- 
pranolol. After 3 h, the concentration of TNF-o~ in the supernatants was 
measured as described  in Materials and Methods.  Results are shown as 
mean  _+  SEM  of three different experiments. 
HP3B1 mAb-, B73.1  mAb-, or PMAomediated effects, ac- 
tinomycin D blunted PA-induced TNF-c~ production (Table 
2).  The PA effect on TNF-o~ biosynthesis was readily ob- 
servable at concentrations between 200 and 500 #g/ml (Fig. 
7).  It is interesting to note that optimal PA concentrations 
necessary to yield maximal TNF-ol production are in the range 
ofintracellular PA levels attained in response to agonist stim- 
ulation, as reported by Bocckino et al. (33), who calculated 
that PA levels rise to 360-720 gg/ml in hormone-treated he- 
patocytes. To assess PA specificity, other phospholipids were 
assayed for their ability to stimulate TNF-o~ production: phos- 
phatidylcholine, phosphatidylethanolamine, phosphatidylino- 
sitol, phosphatidylserine, lysophosphatidylethanolamine, lyso- 
phosphatidylserine, and lysophosphatidic acid. None of these 
compounds were able to mimic the effect of PA in stimulating 
TNF-oe biosynthesis in IL-2-treated NK cells (data not shown). 
Remarkably, when PA-stimulated TNF-o~ production was ex- 
amined in  the presence of propranolol,  the response was 
strongly reduced (Fig. 8). Propranolol, an inhibitor of phos- 
phatidic  acid phosphohydrolase  (34),  has been previously 
shown to prevent phospholipase D-derived DG production 
in human leukocytes (23,  27,  28,  31,  35,  36).  Thus,  these 
data suggest a role for PA-derived DG in TNF-ol synthesis 
by NK cells. Very interestingly, PMA-induced TNF-c~ bio- 
synthesis was partially inhibited by propranolol (Fig. 8), sug- 
gesting that a portion of the PMA effect was secondary to 
enhanced DG production via PA dephosphorylation. 
Discussion 
The present work has provided, to our knowledge, the 
first evidence for receptor-mediated stimulation of phospholi- 
14  Phospholipase D  Activation in Human Natural Killer Cells pase D in human Ib2-treated NK cells. In addition, this study 
has demonstrated that at least two different mechanisms exist 
for receptor activation of NK cell phospholipase D.  Thus, 
it has been shown that phospholipase D activation through 
the CD16 receptor takes place concomitant to phospholipase 
C-catalyzed polyphosphoinositide breakdown and depends 
on extracellular  Ca  2+.  On the other hand, Kp43-induced 
phospholipase D  activation occurs in the absence of poly- 
phosphoinositide turnover and does not depend on external 
Ca  2+ . Altogether, these results give further support to the 
notion that different pathways exist for activation of phos- 
pholipase D  (14, 20,  22,  37).  Moreover,  this  study has 
documented for the first time the existence of two distinct 
receptor-modulated pathways for phospholipase D activation 
within the same cell type. Both routes require, however, a 
threshold Ca  2  + concentration inside the cell, thus indicating 
that, in common with several other phospholipase Ds (37), 
NK cell phospholipase D  requires Ca  2+  for activity.  This 
finding also suggests that occupancy of both Kp43 and CD16 
may lead to activation of the same enzyme. We cannot ex- 
clude, however, the possibility that two different phospholi- 
pase D isoenzymes may exist; one activated through the Kp43 
antigen,  and  the  other  one activated through the CD16 
receptor. Phospholipase D  activity appears to be present in 
cells under multiple isoforms (38, 39). Indeed, involvement 
of different phospholipase D isoenzymes during cell activa- 
tion has recently been suggested in human neutrophils (40). 
The fact that activation of the Ca2+-requiring  NK cell phos- 
pholipase D  appears  to be sustained by Ca  2+  in one case 
(CD16) but not in the other one (Kp43) is somewhat reminis- 
cent of that occurring with phosphoinositide-specific  phos- 
pholipase C  from different tissues. Thus, phosphatidylino- 
sitol hydrolysis  by phospholipase C  is  dependent on and 
stimulated by Ca2+;  whereas,  phospholipase C  attack on 
phosphatidylinositol  4,5-bisphosphate,  although  Ca  2+- 
dependent, is not stimulated by Ca  2+  (41). 
An important aspect of the present work is the finding 
that PA, the physiologic product of phospholipase D action 
on phospholipids, is able to induce TNF-c~ biosynthesis and 
secretion,  a  process  triggered by mAbs specific for both 
Kp43 and CD16 (32)  surface antigens. PA has previously 
been implicated in the regulation of nuclear events, such as 
the induction of c-myc, c-fis, and platelet-derived growth factor 
genes, and the stimulation of DNA synthesis (42-45). In ad- 
dition, PA has also been suggested to act as a second mes- 
senger in receptor-triggered secretory processes in human neu- 
trophils (31, 46). Our data using propranolol suggest, however, 
that in NK cells, the stimulatory effect of PA on TNF-ot syn- 
thesis is accounted for by PA-derived DG rather than by PA 
itself. In addition, our results have revealed that a part of the 
TNF-oe produced by PMA-stimulated cells is propranolol in- 
hibitable,  thus suggesting that PMA effects on TNF-ce syn- 
thesis involve DG generation via PA dephosphorylation. Four 
distinct pathways have been described for DG generation in 
stimulated cells. These are phospholipase C-mediated break- 
down of polyphosphoinositides, phospholipase C attack on 
phospholipids other than phosphoinositides, ceramide/phos- 
phatidylcholine exchange, and phospholipase D/PA phospho- 
hydrolase (47). In as much as the only route for DG produc- 
tion  that  is  sensitive  to  propranolol  is  one  involving 
phospholipase D (47), the data of this study suggest a second 
messenger role for phospholipase D-derived lipid messengers 
in the induction of TNF-c~ gene transcription in human NK 
cells. The putative role of phospholipase  D-derived lipid mes- 
sengers obviously does not exclude the involvement of other 
messenger molecules, particularly for the CD16-triggered 
TNF-oe gene expression, where polyphosphoinositide-specific 
phospholipase C  is certainly activated  (see reference 4). 
In conclusion, our results suggest that phospholipase D 
activation in IIr  NK cells, and the subsequent gener- 
ation of PA and DG, may provide a route for signal transduc- 
tion of great importance for the understanding of NK cell 
biology. The fact that NK cell stimulation via the Kp43 sur- 
face antigen triggers cytotoxicity (8) and leads to phospholi- 
pase D  activation in the absence of a detectable rise in the 
intracellular Ca  2+  concentration suggests a role for phos- 
pholipase D-derived products in  the induction of Ca  2+- 
independent NK cell cytotoxicity (48, 49). Studies are cur- 
rently in progress to elucidate these questions. 
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